Ethypharm a leading specialty pharmaceutical company with a strong heritage, based in the UK. Ethypharm acquired Martindale Pharma in January 2017 creating its position as a leading UK-based specialty pharmaceutical company providing value-adding pharmaceutical products to over 80 countries around the world. We have developed a comprehensive range of medicines to support an individual’s recovery from opioid addiction. Our products include formulations of the three standard molecules in this therapy area; methadone, buprenorphine and naloxone. It is this depth of expertise that makes us a market leader and a trusted supplier of opioid addiction products.